Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...
NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...
First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
This press release is not intended for US or UK media. Ingelheim, Germany and Ridgefield, Conn. Boehringer Ingelheim today announced that The New England Journal of Medicine (NEJM) published results ...
MedPage Today on MSN
Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line
Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...
Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...
Nanyang Technological University, Singapore (NTU Singapore) is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology company Lipigon Pharmaceuticals AB ...
The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...
The 84-year-old Navy veteran, whose real name is Kenny Jary, boasts over 4 million followers across social media platforms ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
A new case report was published in Volume 13 of Oncoscience on March 11, 2026, titled “Erosive pustular dermatosis–like scalp ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results